Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Jorge Cuenca-Escalona"'
Autor:
Jorge Cuenca-Escalona, Beatriz Subtil, Alba Garcia-Perez, Alessandra Cambi, I. Jolanda M. de Vries, Georgina Flórez-Grau
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Tumors educate their environment to prime the occurrence of suppressive cell subsets, which enable tumor evasion and favors tumor progression. Among these, there are the myeloid-derived suppressor cells (MDSCs), their presence being associated with t
Externí odkaz:
https://doaj.org/article/95a90294531543d0b988c583f7fe6799
Autor:
Rens Peeters, Jorge Cuenca-Escalona, Esther A. Zaal, Anna T. Hoekstra, Anouk C. G. Balvert, Marcos Vidal-Manrique, Niek Blomberg, Sjoerd J. van Deventer, Rinke Stienstra, Julia Jellusova, Martin Giera, Luciana Hannibal, Ute Spiekerkoetter, Martin ter Beest, Celia R. Berkers, Annemiek B. van Spriel
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-18 (2022)
Tetraspanin CD37 deficiency has been reported as a prognostic marker for aggressive B-cell lymphoma. Here, the authors show that CD37 interacts with the fatty acid transporter 1 to inhibit palmitate uptake and its deficiency leads to increased fatty
Externí odkaz:
https://doaj.org/article/06b391ff93194e52ab905cd0ab30f079
Autor:
Carl G Figdor, I Jolanda M de Vries, Camille Le Gall, Anna Cammarata, Lukas de Haas, Iván Ramos-Tomillero, Jorge Cuenca-Escalona, Kayleigh Schouren, Zacharias Wijfjes, Anouk M D Becker, Johanna Bödder, Yusuf Dölen, Georgina Flórez-Grau, Martijn Verdoes
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 10, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/cb3adf0d6b7342ed8ed2d2b302e22501
Autor:
Beatriz Subtil, Kirti K. Iyer, Dennis Poel, Lotte Bakkerus, Mark A. J. Gorris, Jorge Cuenca Escalona, Koen van den Dries, Alessandra Cambi, Henk M. W. Verheul, I. Jolanda M. de Vries, Daniele V. F. Tauriello
Publikováno v:
Frontiers in Immunology, 14:1105244. Frontiers Media S.A.
Frontiers in Immunology, 14
Frontiers in Immunology, 14
Colorectal cancer (CRC) remains one of the most aggressive and lethal cancers, with metastasis accounting for most deaths. As such, there is an unmet need for improved therapies for metastatic CRC (mCRC). Currently, the research focus is shifting tow
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10e2426d19716bd7aa0888cb1afbe10d
https://pure.eur.nl/en/publications/ecf8b1dc-088b-4bb0-b4c2-f8ee8c1630c6
https://pure.eur.nl/en/publications/ecf8b1dc-088b-4bb0-b4c2-f8ee8c1630c6
Autor:
Camille Le Gall, Anna Cammarata, Lukas de Haas, Iván Ramos-Tomillero, Jorge Cuenca-Escalona, Kayleigh Schouren, Zacharias Wijfjes, Anouk M D Becker, Johanna Bödder, Yusuf Dölen, I Jolanda M de Vries, Carl G Figdor, Georgina Flórez-Grau, Martijn Verdoes
Publikováno v:
Journal for Immunotherapy of Cancer, 10, 4
Journal for ImmunoTherapy of Cancer
Journal for Immunotherapy of Cancer, 10
Journal for ImmunoTherapy of Cancer
Journal for Immunotherapy of Cancer, 10
BackgroundType 1 conventional dendritic cells (cDC1s) are characterized by their ability to induce potent CD8+T cell responses. In efforts to generate novel vaccination strategies, notably against cancer, human cDC1s emerge as an ideal target to deli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f4851762718d0b72450b725e0e60926
https://doi.org/10.1136/jitc-2021-004309
https://doi.org/10.1136/jitc-2021-004309
Autor:
Carmen Ramírez-Castillejo, Raúl Moreno, María-Pilar López-Garrido, Enrique Arias, Carmen Gil-Gas, Carmen Belen Alvarez-Simón, Jose Luis Sánchez-Sánchez, Francisco Sánchez-Sánchez, Jorge Cuenca-Escalona, Ana Ferrer Perez, Paloma Honrubia-Gómez
Publikováno v:
Oncotarget, 10, 31, pp. 2973-2986
Oncotarget, 10, 2973-2986
Oncotarget, ISSN 1949-2553, 2019-04, Vol. 10, No. 31
Archivo Digital UPM
Universidad Politécnica de Madrid
Oncotarget
Oncotarget, 10, 2973-2986
Oncotarget, ISSN 1949-2553, 2019-04, Vol. 10, No. 31
Archivo Digital UPM
Universidad Politécnica de Madrid
Oncotarget
Contains fulltext : 215685.pdf (Publisher’s version ) (Open Access) Relapse after chemotherapy treatment depends on the cancer initiating cells (CICs). PEDF (Pigmented Epithelium Derived Factor) is an anti-angiogenic, neurotrophic and self-renewal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd116a8f0047e7632a3a448ee61f99f
https://hdl.handle.net/2066/215685
https://hdl.handle.net/2066/215685
Autor:
Georgina Flórez-Grau, Jorge Cuenca Escalona, Helena Lacasta-Mambo, Daphne Roelofs, Johanna Bödder, Ruben Beuk, Gerty Schreibelt, I Jolanda de Vries
Publikováno v:
Bio-Protocol, Vol 13, Iss 20 (2023)
Dendritic cells have been investigated for cell-based immunotherapy for various applications. The low abundance of dendritic cells in blood hampers their clinical application, resulting in the use of monocyte-derived dendritic cells as an alternative
Externí odkaz:
https://doaj.org/article/5596e6fff6f848719c1d78e5a216c12d